Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the medical community with cutting-edge regenerative therapies. The final purchase price, which will be negotiated by the Parties, will include the issuance of equity in Emergent (OTC PINK:EMGE) and defined capital investment into Evolutionary Biologics for sales, scaling of company operations, and promotions, all based on projections, and subject to funding, as negotiated and agreed upon by Emergent (OTC PINK:EMGE) and Evolutionary. The products ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Emergent executes a letter of intent to acquire Evolutionary Biologics; former L’Oréal president Jim Morrison will become Emergent’s full-time chief executive officer.